FHC
BMRN icon

First Horizon Corporation’s BioMarin Pharmaceuticals BMRN Stock Holding History

First Horizon Corporation’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$26K Hold
318
– – ﹤0.01% 503
2021
Q1 		$24K Sell
318
-227
-42% -$18.5K ﹤0.01% 506
2020
Q4 		$47K Buy
545
+49
+10% +$3.88K ﹤0.01% 376
2020
Q3 		$37K Buy
+496
New +$50.2K ﹤0.01% 381

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

First Horizon Corporation's BMRN Position: Q2 2021 in Review

First Horizon Corporation held its BioMarin Pharmaceuticals (BMRN) position steady in Q2 2021 at 318 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #503.

First Horizon Corporation first reported a position in BMRN in Q3 2020 and has held it in 4 quarters since. The position peaked at $47K in Q4 2020. 529 funds tracked by Wall St. Rank hold BMRN as of Q2 2021.

  • First Horizon Corporation held 318 shares of BioMarin Pharmaceuticals worth $26K as of Q2 2021.
  • First Horizon Corporation left its BioMarin Pharmaceuticals share count unchanged in Q2 2021.
  • BioMarin Pharmaceuticals made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2021, its #503 holding.
  • First Horizon Corporation first reported a position in BioMarin Pharmaceuticals in Q3 2020 and has held it in 4 quarters since.
  • First Horizon Corporation's BioMarin Pharmaceuticals position peaked at $47K in Q4 2020.
  • 529 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2021.

Based on First Horizon Corporation's 13F filing for Q2 2021, filed 9 Aug 2021.